Veradermics Incorporated (MANE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 21,766 | 53,084 |
| Marketable Securities | 120,096 | N/A |
| Other current assets | 10,632 | 2,451 |
| TOTAL | $152,494 | $55,535 |
| Non-Current Assets | ||
| PPE Net | 22 | N/A |
| Other Non-Current Assets | 103 | 0 |
| TOTAL | $125 | $N/A |
| Total Assets | $152,619 | $55,535 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 2,126 | 2,248 |
| Accrued Expenses | 6,979 | 2,470 |
| Other current liabilities | 47 | N/A |
| TOTAL | $9,152 | $4,718 |
| Non-Current Liabilities | ||
| Other Non-Current Liabilities | 264,481 | 99,297 |
| TOTAL | $264,481 | $99,297 |
| Total Liabilities | $273,633 | $104,015 |
| Shareholders' Equity | ||
| Common Shares | 1 | 1 |
| Retained earnings | -123,421 | -49,231 |
| Other shareholders' equity | 60 | 0 |
| TOTAL | $-121,014 | $-48,480 |
| Total Liabilities And Equity | $152,619 | $55,535 |